12 Sources of evidence considered by the Committee

12 Sources of evidence considered by the Committee

The diagnostics assessment report was prepared by Kleijnen Systematic Reviews Ltd.

  • Westwood ME, van Asselt ADI, Ramaekers BLT et al. (2014) High‑sensitivity troponin assays for the early rule‑out or diagnosis of acute myocardial infarction in people with acute chest pain.

Registered stakeholders

The following organisations accepted the invitation to participate in this assessment as registered stakeholders. They were invited to attend the scoping workshop and to comment on the diagnostics assessment report and the diagnostics consultation document.

Manufacturers of technologies included in the final scope:

  • Abbott Diagnostics UK

  • Beckman Coulter UK Ltd.

  • Roche Diagnostics Ltd

Other commercial organisations:

  • Alere Ltd

  • Juniper Consulting Group

  • Randox

  • Siemens

  • Singulex

  • Thermo Fisher Scientific

Professional groups and patient/carer groups:

  • Association for Clinical Biochemistry and Laboratory Medicine

  • British Cardiovascular Intervention Society

  • British Society for Cardiovascular Research

  • Royal College of Nursing

  • South Asian Health Foundation

Research groups:

None

Associated guideline groups:

None

Others:

  • Department of Health

  • Healthcare Improvement Scotland

  • NHS England

  • Welsh Government

  • National Institute for Health and Care Excellence (NICE)